More than a million people receive a vital vaccination every year that can protect four out of five against severe illness.

RSV is a common respiratory virus that typically causes mild, cold-like symptoms, such as a runny nose, coughing, sneezing and sometimes a fever. However, it can be dangerous in some people, ...

ABRYSVO, a bivalent vaccine, maintained consistently high protective efficacy for both RSV A and RSV B disease through two seasons after a single dose. ABRYSVO efficacy was 77.8% against RSV lower ...

Millions of older people are being urged to get a key jab for the first time.

What’s the RSV Timeline? Respiratory syncytial virus (RSV) is a common respiratory virus. Most people have it before age 2, but older kids and adults also get it. RSV symptoms in adults usually go ...